ONE Nanotechnologies
Mesoporous Sensors for Proteomics & Small Molecules
Innovation is our passion!
We create faster, more accurate, and more cost-effective tools for biomarker analysis, making more efficient and precise human health diagnostics possible. Our patent-pending technology measures proteins and other disease and cancer biomarkers through the use of precisely printed photonic nanodevices. By combining innovation with passion we develop and bring novel nanotechnology to the marketplace.
Early disease detection uses biochemical processes to find biomarkers. These biochemicals add complexity, variability and error to the results. Specificity and simplicity are better! Our technology provides both specificity and simplicity without use of antibodies. Our chips are optimized for the detection of particular breast cancer, colorectal cancer, lung cancer and ovarian cancer, as well as heart disease biomarkers. These five diseases are responsible for the majority of non-accident death in Europe and North America.
Extending our thin films technology into the realm of chemical threat detection, our approach has been shown to be an effective discrimination system for biochemical and energetic materials. Nerve agent surrogates and RDX have been identified as trace constituents in air and water. Electronic discrimination of chemical and biochemical threats addresses key issues in environmental health and safety as well as food security and military applications.
Please see our founder's Lithography blog on
SemiNeedle (click here)
Rob's publications in FutureFab International:
The Emergence of Bionanotechnology, Part IThe Emergence of Bionanotechnology, Part 2
Sub 30nm Photoresist Design Considerations: Molecular Nanotechnology
latest news
10/23/11
Rob presented "Bootstrapping through DIY low cost instruments"
at the Open Science Summit at the Computer History Museum in Mountain View, California.
9/18/11
Rob co-presented for the "Meta-Insights Panel" for the Thiel 20Under20 Fellows at the Presideo in San Francisco, California
8/11/11
ONE Nanotechnologies, LLC and Lucent Solar, Inc. have
formed a technology partnership for the joint development of low cost plasma processes & equipment.
6/13/11
200mm tool celebrates 1st plasma today.
The migration of the plasma modulefrom the test bed to the 200mm tool
was smooth, and test bed will focus on differential pumping development.
5/30/11
Rob will lecture
and sit on 2 panels at the Foresight Institute's 25th Anniversary Reunion Conference.
4/30/11
Rob presented "Surface Selective Sensing of Small and Macro-molecules"
at the Berkeley Nanotechnology Forum at University of California,
Berkeley.
4/26/11
Rob taught "Introduction to nanolithography" seminar at the University
of Arizona, Tucson as a part of Prof. Philipossian's CHEE/ECE 415/515
class.
4/21/11
Rob presented "Engineering Biomolecules with Nanotechnology" as the
kick off lecture for the Foresight Institute's 2011 lecture series.
4/15/11
ONE Nanotechnologies, LLC completed third chemical sensor collaboration agreement with Advanced MEMS, Inc of Berkeley,
CA demonstrating repeatability for QCM coatings for the detection of nerve agents.
12/25/10
ONE Nanotechnologies, LLC acquired the core technology and prototypes from EHDT Group, Inc of Duarte CA developing
Electrospray-PECVD technology(3 issued US Patents)
5/27/10
ONE Nanotechnologies, LLC completed a 5 month consulting
agreement with EHDT Group, Inc of Duarte CA developing Electrospray-PECVD technology.
5/6/10
ONE Nanotechnologies, LLC completed second chemical sensor collaboratiopn adgreement with Advanced MEMS, Inc of Berkeley,
CA demonstrating proof-of-concept of QCM coatings for the detection of waterborn nerve agents and high energy materials.
4/27/10
ONE Nanotechnologies, LLC completed a 5 month consulting agreement with EHDT Group, Inc of Duarte
CA developing
Electrospray-PECVD technology.
12/15/09
ONE Nanotechnologies, LLC completed a 3 month consulting agreement with Silexos, Inc of Menlo
Park developing advanced MOCVD materials. Rob accepted a role as Director of Materiasl Development.
9/26/09
ONE Nanotechnologies, LLC completed first chemical sensor collaboratiopn adgreement with Advanced MEMS,
Inc of Berkeley, CA demonstrating proof-of-concept of QCM coatings for the detection of airborn nerve agents.
5/11/09
We welcome Mr. Michael Rattner of Advanced MEMS, LLP to our team!
5/5/09
Dr. Meagley presnted "Nanostructures for biomarker selection and
identification by MS" at the NSTI Nanotech09 TechConnect Summit.
2/12/09
Dr. Meagley attends annual meeting of the Univ. of Wisconsin
NSEC advisory board.
1/18/09
ONE Nanotechnologies, LLC and Advanced MEMS Inc. have
formed a technology partnership to foster synergy between their technology
portfolios and R&D capabilities.
9/1/08
ONE Nanotechnologies, LLC
closed its second consulting agreement with Naosys, Inc of Palo Alto
developing advanced nanodot memory materials.
6/6/08
ONE Nanotechnologies, LLC closed its first
consulting agreement with Nanosys, Inc. of Palo Alto. Work focussed
on inventing next generation isolation materials, ligands and
environmentally friendly formulations fortheir nanodot memory program.
6/3/08
Dr. Meagley presented "Selective Identification of Proteins by Laser
Desorption Ionization Mass Spectrometry on Photonic Nanodevices Coupled to
Abiotic Receptors" to the NSTI Nanotech '08 conference in Boston Read our recent paper from NSTI '08!.
Dr. Meagley presented "Protein selection by nanophotonic
receptors" as an invited talk for Honeywell at SPIE in
Dr. Meagley attends
Successful testing of ONE Nano's first generation
prototype. Patents filed on proprietary design.
Dr.